A microfluidic spray drying approach for developing lipid nanoparticles dry powder via anti-solvent precipitation

• Constructed a microfluidic platform that combines the principle of anti-solvent precipitation and spray drying. • The microfluidic spray drying platform can be used to prepare lipid nanoparticles dry powder in one step. • Prepared uniform-sized Rg3-loaded lipid nanoparticles. • Prepared lipid nanoparticles dry powder with long-term storage stability. • Compared with free Rg3, Rg3-SD LNPs exhibit high oral bioavailability. The development of novel drug dosage forms with high drug activity and enhanced bioavailability continues to pose a significant challenge in the pharmaceutical industry. Currently, lipid nanoparticles (LNPs) have been widely recognized as safe and efficient nanomedicine delivery systems; however, they exhibit thermodynamic instability. To address these challenges, this study developed a novel microfluidic spray drying (MFSD) platform by integrating the anti-solvent precipitation (ASP) method with gas spray drying, enabling continuous preparation of Rg3-loaded spray-dried lipid nanoparticles (Rg3-SD LNPs) dry powder. Key parameters, including solvent/antisolvent concentration, flow rate ratio, and gas pressure, were optimized to produce monodisperse and stable nanoparticles. The influence of excipient type, concentration, and heating temperature on dry powder was also investigated. Characterization confirmed long-term stability of the dry powder and low organic solvent residue, while in vivo pharmacokinetic study in rats demonstrated significantly enhanced bioavailability. The obtained LNPs dry powder demonstrated enhanced long-term storage stability and oral bioavailability, effectively overcoming the problems of thermodynamic instability of LNPs and low bioavailability of poorly soluble drugs. This study underscores the potential of the MFSD platform as a scalable and efficient approach to enhance the solubility, long-term storage stability, and bioavailability of poorly water-soluble drugs and provides a practical and feasible method for preparing LNPs dry powder.

Authors

Institutions

Publication Details

Journal
Chemical Engineering Journal Advances
Published
2026-02-03
DOI
https://doi.org/10.1016/j.ceja.2026.101073
Primary Topic
Advancements in Transdermal Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A microfluidic spray drying approach for developing lipid nanoparticles dry powder via anti-solvent precipitation

Zhu Yang, Yipiao Zhang, Suhong Chen, Hongliang Zheng et al.
Chemical Engineering Journal Advances
Advancements in Transdermal Drug Delivery
article

A microfluidic spray drying approach for developing lipid nanoparticles dry powder via anti-solvent precipitation

Zhu Yang, Yipiao Zhang, Suhong Chen, Hongliang Zheng, Xingchen Zhou, Chuanpin Chen, Yang Liu
article en

Abstract

• Constructed a microfluidic platform that combines the principle of anti-solvent precipitation and spray drying. • The microfluidic spray drying platform can be used to prepare lipid nanoparticles dry powder in one step. • Prepared uniform-sized Rg3-loaded lipid nanoparticles. • Prepared lipid nanoparticles dry powder with long-term storage stability. • Compared with free Rg3, Rg3-SD LNPs exhibit high oral bioavailability. The development of novel drug dosage forms with high drug activity and enhanced bioavailability continues to pose a significant challenge in the pharmaceutical industry. Currently, lipid nanoparticles (LNPs) have been widely recognized as safe and efficient nanomedicine delivery systems; however, they exhibit thermodynamic instability. To address these challenges, this study developed a novel microfluidic spray drying (MFSD) platform by integrating the anti-solvent precipitation (ASP) method with gas spray drying, enabling continuous preparation of Rg3-loaded spray-dried lipid nanoparticles (Rg3-SD LNPs) dry powder. Key parameters, including solvent/antisolvent concentration, flow rate ratio, and gas pressure, were optimized to produce monodisperse and stable nanoparticles. The influence of excipient type, concentration, and heating temperature on dry powder was also investigated. Characterization confirmed long-term stability of the dry powder and low organic solvent residue, while in vivo pharmacokinetic study in rats demonstrated significantly enhanced bioavailability. The obtained LNPs dry powder demonstrated enhanced long-term storage stability and oral bioavailability, effectively overcoming the problems of thermodynamic instability of LNPs and low bioavailability of poorly soluble drugs. This study underscores the potential of the MFSD platform as a scalable and efficient approach to enhance the solubility, long-term storage stability, and bioavailability of poorly water-soluble drugs and provides a practical and feasible method for preparing LNPs dry powder.

Chemical Engineering Journal AdvancesVol. 26
Zhejiang Chinese Medical University (CN), Central South University (CN), Shanghai Innovative Research Center of Traditional Chinese Medicine (CN), Quzhou City People's Hospital (CN), Quzhou University (CN), Xiangya Hospital Central South University (CN), Zhejiang University of Technology (CN)
Industry, innovation and infrastructure
Openalex Percentile: Top 67%
Advancements in Transdermal Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.